FDA’s Center for Drug Evaluation and Research

MedTech

FDA Approves First Alzheimer's Drug to Slow Disease Progression

The US FDA has granted full approval to Leqembi, a breakthrough Alzheimer's drug developed by Eisai and Biogen.